Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial
- Disease/Condition
- Gastroparesis
- Drug/Device/Intervention
- Endoscopic per-oral pyloromyotomy (POP)
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- The Cleveland Clinic
- Location
- Cleveland, United States of America
- Phase
- N/A
- Start date
- Feb 23, 2022
- End date
- Jul 01, 2026
- Enrollment
- 100 participants
Gastroparesis Cardinal Symptom Index (GCSI)
A randomized clinical trial comparing endoscopic per-oral pyloromyotomy (POP) versus a
 control sham intervention (diagnostic esophagogastroduodenoscopy (EGD) without pyloric
 disruption) in patients with medically refractory gastroparesis.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05039424
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05039424 through Pure Global AI's free database. This phase not specified trial is sponsored by The Cleveland Clinic and is currently Recruiting. The study focuses on Gastroparesis. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.